| Name | 1 n6-ethenoadenosine free base |
|---|---|
| Synonyms |
(2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(3H-imidazo[2,1-i]purin-3-yl)tetrahydrofuran-3,4-diol
1,N(sup 6)-ethenoadenosine 3-β-D-Ribofuranosyl-3H-imidazo[2,1-i]purine N6-Ethenoadenosine 3H-Imidazo[2,1-i]purine, 3-β-D-ribofuranosyl 3H-Imidazo[2,1-i]purine,3-b-D-ribofuranosyl 3-(β-D-Ribofuranosyl)-3H-imidazo[2,1-i]purine ETHENOADENOSINE, MORPURE HPLC PURIFIED, DELIVERED >= UV CHROMATOAM Ethenoadenosine 1,N6-etheno-adenosine 3-(β-D-Ribofuranosyl)-3,5a-dihydro-1,3,4,5a,8-pentaaza-as-indacene 1 N6-ETHENOADENOSINE FREE BASE 1,N6-ethanoadenosine |
| Description | 1,N6-Ethenoadenosine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.99g/cm3 |
|---|---|
| Molecular Formula | C12H13N5O4 |
| Molecular Weight | 291.26 |
| Exact Mass | 291.09700 |
| PSA | 117.93000 |
| Index of Refraction | 1.915 |
| Precursor 8 | |
|---|---|
| DownStream 2 | |